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Abstract 
Objectives: Dispositional Mindfulness (DM) has become an important construct in 
understanding and treating Fibromyalgia. However, few DM measures exist that have been 
validated in those with fibromyalgia. The Philadelphia Mindfulness Scale (PMS) is a self-
report of DM. In the current study we validate the PMS within a sample of individuals with 
fibromyalgia.  
Design: This was a cross-sectional online study. This enabled the recruitment of a larger 
sample of individuals with experiences of fibromyalgia than may have been achieved through 
face-to-face assessment. A cross-sectional approach was adopted to minimise resource 
demands.  
Method: The PMS alongside measures of fibromyalgia severity (The Revised Fibromyalgia 
Impact Questionnaire), affect (Positive and Negative Affect Scale), and decentring 
(Experiences Questionnaire) were completed online by a sample of N = 936 individuals with 
fibromyalgia.  
Results: Confirmatory factor analysis supported a revised three-factor structure for the PMS. 
This factor structure excluded items which could overlap with hypervigilance within 
fibromyalgia.  The three supported factors were Awareness, Non-judging /Control and Non-
suppression/reactivity. Concurrent validity of the subscales was partially supported via 
correlations with positive and negative affect and decentring. 
Conclusions: The results support the use of the PMS in individuals with fibromyalgia, and in 
particular the use of this measure to compare those with and without experience of 
meditation. The PMS may be a useful tool in evaluating mindfulness based interventions 
within this population. 
Limitations: The online design prevented more in-depth assessment of fibromyalgia. As the 
study was cross-sectional test re-test reliability could not be assessed. 
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Validating the Philadelphia Mindfulness Scale for Those with Fibromyalgia 
Fibromyalgia is a specific chronic pain condition of unknown aetiology characterised 
by ongoing pain in the soft tissues of the body.1 Fibromyalgia is associated with considerable 
psychological distress and disorder, with greater levels in this group than the general population 
and those with other chronic pain conditions.2,3 In the context of traditional medical approaches 
showing little benefit,4-6 Mindfulness-Based Interventions (MBIs) are continuing to 
demonstrate their efficacy in improving the well-being of individuals with fibromyalgia.8,9 
Within a clinical context, MBIs are interventions which focus on mindfulness as a trainable 
skill through regular meditation practice. Mindfulness may also be considered a dispositional 
trait (Dispositional Mindfulness; DM).10 That is, mindfulness may be described as the ability 
to maintain moment to moment awareness in both an open and accepting way,11 and individuals 
seem to differ in their natural tendency to respond to their experiences in this way. Evidence 
suggests that levels of mindfulness without training remain stable over time.12 The 
measurement of DM and its key underlying dimensions in those experiencing fibromyalgia is 
therefore important for both research evaluating MBIs and clinicians working within those with 
fibromyalgia who use a mindfulness-based framework. The current study focuses on the 
psychometric evaluation of a DM measure, the Philadelphia Mindfulness Scale (PMS)13 in a 
fibromyalgia population.  
Bishop and colleagues 14 propose that mindfulness consists of two broad facets: the 
ability to sustain attention to the present moment, and the ability to adopt a stance of acceptance 
characterised by being non-judgemental, open and curious. These qualities of acceptance and 
awareness may be beneficial to those with fibromyalgia, because they run counter to 
maladaptive emphasis on controlling the pain, such as through avoidance of activity, which 
ultimately further maintain both pain and distress.15,16 Likewise, a focus on the present moment 
is incompatible with worry or rumination, which again is common in chronic pain.16 
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Cardaciotto and colleagues 13 developed the PMS specifically based on Bishop and colleagues’ 
definition of mindfulness. It is a 20-item measure consisting of two orthogonal dimensions 
measuring awareness and acceptance.  
Other widely used measures of DM exist. The Mindfulness Attention and Awareness 
Scale (MAAS)10 is a 15-item self-report measure of DM. The validity of the MAAS as a 
measure of DM has been supported 10 but this measure has also been criticised because items 
do not fully capture the “acceptance” facet of mindfulness (i.e., being able to accept negative 
states without trying to avoid or push these away) proposed by Bishop and colleagues.14 The 
Five Facet Mindfulness Questionnaire (FFMQ)12 is another measure of DM that was developed 
to specifically assess change in mindfulness skills within the context of interventions. It 
encompasses a broader definition of mindfulness which includes: Non-Reactivity to Inner 
Experience; Observing/Noticing; Acting with Awareness; Describing; and Non-Judging of 
Experience.12 However, the scale has also been criticised, with the suggestion that the “Non-
reactivity” subscale might be better conceptualised as an outcome of DM.14  
The PMS benefits from an a priori definition of mindfulness and is also short enough 
not to be too demanding to complete by fibromyalgia populations.13 Whilst the above DM 
measures have been used in samples experiencing chronic pain, the underlying factor structure 
has not been confirmed amongst such samples, at least with English-language versions of these 
measures (although see other-language validation studies)17-20. Establishing the factor structure 
of DM measures within chronic pain samples is necessary to ensure subscale scores map onto 
meaningful underlying factors. In the current study we therefore subject the PMS to a CFA 
within a chronic pain sample, those with fibromyalgia. 
The hypothesised two-factor structure of the PMS was supported both by Exploratory 
Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) in a sample of students,13 
but not those with chronic pain. The CFA did not account for the ordinal nature of the items 
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in the PMS, which may have biased fit indices to some extent (Kline, 2011). Cardaciotto and 
colleagues 13 suggest a number of residual correlations (k = 6) that improved the fit of their 
two factor model. In the current paper we test both models (i.e., two factors and two factors 
with correlated errors) as part of our CFA. An alternative factor structure can be suggested by 
reviewing the item content of the PMS. Notably, within the acceptance subscale, there appear 
to be two types of question. The first relate specifically to active attempts to suppress or 
avoid unwanted thoughts and feelings (e.g., “I try to distract myself when I feel unpleasant 
emotions”) whilst the second refer to a feeling that one should be able to control or should 
not experience certain thoughts or emotions (e.g., “I tell myself that I shouldn’t have certain 
thoughts”). The former represents an active, emotion-focussed, coping process (e.g., thought 
suppression and distraction). Alternatively, the latter reflects a judgement on whether certain 
thoughts and feelings are appropriate or should be suppressed or controlled. These can be 
likened to the concept of meta-beliefs concerning internal states.21 These two dimensions 
have similarities with the non-reactivity and non-judging subscales of the FFMQ.12 Hence an 
a priori three factor structure for the PMS could be hypothesised with Awareness, Non-
suppression/reactivity, and Non-judging/control as factors. 
 A question pertinent to the current paper is the extent to which those dimensions of 
DM established in other populations would apply to a sample of individuals experiencing 
chronic pain, specifically fibromyalgia. A notable psychological feature of those experiencing 
fibromyalgia is hypervigilance to internal states, possibly including both physical sensation 
and negative thoughts and feelings.22,23 A number of items in the PMS awareness subscale 
may inadvertently capture this hypervigilance, particularly those items that refer to shifts in 
physical (“I notice changes inside my body, like my heart beating faster or my muscles 
getting tense”) and emotional (“I am aware of thoughts I’m having when my mood changes”) 
states. Therefore we also consider a revised three-factor structure for the PMS where we 
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exclude those items from the Awareness subscale which focus on internal states. This leaves 
an Awareness factor focused on awareness of external events (“When talking with other 
people, I am aware of their facial and body expressions”) and sensory experience (e.g., 
“When I shower, I am aware of how the water is running over my body”). 
It is also important that the PMS can be used to make meaningful comparisons across 
relevant subgroups of those with fibromyalgia. For example, comparisons between those with 
greater or lesser experience of meditation are important in determining whether mindfulness 
meditation based interventions are effective. Moreover, there is evidence that the structure of 
DM measures may vary as a function of meditation experience24 limiting the extent to which 
such comparisons can be made. Whether the factor structure remains the same across 
subgroups is a matter of factor invariance 25 and his will be tested in the current paper for 
meditators and non-meditators. 
In addition we assessed concurrent validity by testing theorised relationships with 
decentring, positive (PA) and negative affect (NA). It has been consistently demonstrated that 
mindfulness positively correlates with PA and negatively correlates with NA.26 It has been 
proposed that mindfulness through intervention leads to improvements in well-being via 
increased decentering,27-29 which is a fundamental metacognitive shift in the ability to recognise 
one’s thoughts as thoughts, rather than necessarily true facts.27 Fresco and colleagues explicitly 
state that they do not see their definition (and associated Experiences Questionnaire)27 as 
synonymous with mindfulness as defined by Bishop and colleagues14; rather, they feel it is 
complimentary to it. They also note that Bishop and colleagues14 themselves consider 
mindfulness and decentering are not redundant concepts. To clarify, mindfulness enables an 
individual to focus on experiences in the present moment with acceptance and curiosity, but it 
is the process of decentering that is hypothesised to specifically facilitate an individual to 
recognise the thoughts they are noticing are just thoughts, as opposed to definite truths about 
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the self. It is predicted, therefore, that the PMS would be positively correlated with decentering 
in that individuals with higher levels of DM will also reported an increased ability to decentre.  
 The current study aimed to validate the PMS within a sample of those with 
fibromyalgia. We initially undertake a CFA comparing five alternative factor models: i) a 
single factor model; ii) the two-factor (Awareness, Acceptance) model initially theorised and 
supported by Cardaciotto and colleagues13; iii) Cardaciotto and colleagues two-factor model 
with correlated error terms; iv) a three factor model outlined in this paper (Awareness, Non-
suppression/reactivity, Non-judging/control); and v) a revised four-factor model whereby 
those items concerning awareness of internal states and state shift are excluded. Identifying 
the optimal factor structure within this population is essential in order to derive meaningful 
and informative subscale totals from such measures, and also provides valuable theoretical 
insights into the psychological architecture of these constructs. We also test concurrent 
validity via associations between the PMS, NA, PA and decentring. Specifically, we 
hypothesise that awareness would positively, moderately correlated with Awareness, and that 
Non-suppression/reactivity and Non-judging/control would have positive moderate 
relationships with PA and negative moderate relationships with NA. An online survey was 
used to recruit a large sample of individuals with self-reported fibromyalgia, with decentring 
assessed via the Experiences Questionnaire 27, Fibromyalgia severity via the Revised 
Fibromyalgia Impact Questionnaire30 and affect with the widely used Positive and Negative 
Affect Scale.31 
Method 
Participants & Procedures 
A community sample comprising 936 individuals with self-reported fibromyalgia 
participated in the study.  The sample consisted of 873 women and 63 men, with a mean age 
of 47.97 years (SD = 10.82, range 19-82 years). Inclusion criteria required that participants (i) 
reported confirmation of a clinical diagnosis of fibromyalgia, (ii) were aged 18 years or older 
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and (iii) were a resident of the United Kingdom (UK). Fibromyalgia-related difficulties 
assessed on the Revised Fibromyalgia Impact Questionnaire (FIQR)30; were similar to levels 
reported in other studies for this population (Current sample = 68.54; sample from Bennett et 
al30 = 59.7; see Table 1). 
Eighty percent of the sample (N = 753) reported taking medication to manage their 
fibromyalgia symptoms, and 28% (N = 260) had previously completed some form of 
mindfulness-based intervention.  Fifteen percent (N = 144) reported having practiced 
meditation for less than a year, 9% (N = 81) had practised for one to five years and 10% (N = 
90) reported having practiced meditation for five or more years. However, most of the sample 
had not practiced any kind of meditation (66%; N = 621). 
Following university ethical approval, the study was advertised via two national 
fibromyalgia charities in the UK. Participants took part by following a link placed on the 
advert that took them to the webpage containing the survey. The internet based online study 
required approximately 15 minutes to complete the questionnaires.  
Measures 
The Revised Fibromyalgia Impact Questionnaire (FIQR)30 was used to assess 
fibromyalgia related difficulties. The FIQR is a 21-item measure which covers functional 
status, (e.g., “fibromyalgia made it difficult to [brush or comb your hair]”), overall impact 
(e.g., “Fibromyalgia prevented me from accomplishing goals for the week”), and presence of 
common FM symptoms (e.g., “Please rate your level of [pain])”. Participants are asked to 
think about how FM has impacted on their life over the last seven days. Items are rated on an 
11-point Likert scale ranging from 0 to 10, with higher scores indicating that their FM has 
had a greater impact on their life. Total scores are scaled so that they range from 0 to 100. 
The FIQR has demonstrated good validity in distinguishing those with FM from healthy 
controls, individuals with rheumatoid arthritis and individuals with lupus (Bennett et al., 
2009).  In this present study, Cronbach’s alpha was .95. 
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Philadelphia Mindfulness Scale (PMS).13 The PMS is a 20-item scale designed to 
measure mindfulness based on Bishop and colleagues (Bishop et al., 2004) operationalized 
definition. Each item is rated on a Likert scale ranging from 1 (never) to 5 (very often). 
Reliabilities were acceptable for the awareness (.80) and acceptance subscales (.85). A full 
list of items is presented in Appendix I. 
Positive and negative affect scale (PANAS).31 The PANAS is a well-established and 
validated measure of positive affect (PA) and negative affect (NA).The 20-item scale, 
comprises 10 PA (e.g., active) and 10 NA (e.g., irritable) items. Participants rated each item 
to the extent to which they have experienced each affect item during the past week on a 
Likert scale ranging from 1 (very slightly) to 5 (extremely). The construct validity, reliability 
and concurrent validity of these scales is well supported.32 In the present study Cronbach’s 
alphas were .91 and .90 for PA and NA, respectively.  
Experiences Questionnaire (EQ).27 The decentring subscale of the EQ was used to 
assess decentring. This subscale comprises 11-items (e.g., I can observe unpleasant feelings 
without being drawn into them). Each item is rated on a Likert scale ranging from 1 (never) to 
5 (all of the time). The subscale has evidenced concurrent and discriminant validity as 
demonstrated by positive correlations with cognitive re-appraisal and negative correlations 
with depressive rumination, experimental avoidance and emotional suppression (Fresco et al. 
2007). Reliability in the present study was .87. 
Statistical Analysis 
 Due to the ordinal nature of the items in the PMS the CFA were undertaken using 
Mean and Variance Weighted Least Squares (WLSMV) estimation with the polychoric 
correlation matrix between items used as the input. This approach has been shown to work 
well in the context of ordinal data.33 Analyses were undertaken using Mplus Version 7.2.34 
Reverse items were reflected so that for all items higher scores suggested greater DM. Model 
12 
 
 
fit to the data was based upon a Confirmatory Fit Index (CFI; adequate fit > .90, good fit > 
.95), Tucker-Lewis Index (TLI; adequate fit > .90, good fit > .95) and Root Mean Squared 
Residual (RMSEA; adequate fit < .08, good fit < .06).35-37 
 Factor invariance was assessed at three hierarchical levels: dimensional & configural 
invariance; metric invariance and scalar invariance.25 Dimensional & configural invariance 
was based upon estimating the best fitting model from the analyses of the full sample 
separately with each sub-sample. If the fit remained adequate for both groups and 
standardized factor loadings remained good (e.g., > .4)38 then dimensional and configural 
invariance was present. Metric invariance was assessed by comparing a nested model 
whereby factor loadings were constrained to be equal across groups against a model where 
these are free to vary. Metric invariance is seen as present if the more restrictive model 
(factor loadings constrained) is not a significantly worse fit, as determined via the scaled Χ2 
difference test.39 Scalar invariance follows metric invariance and involves comparing a model 
with both factor loadings and indicator thresholds held constant across groups against a 
model where thresholds (but not loadings) are free to vary. 
Results 
Descriptive Statistics 
Mean descriptive statistics for the key study variables are reported in Table 1. Male and 
female participants did not significantly differ on any of these variables (all p’s > .05). 
Individuals who were taking medication reported significantly higher levels of NA, t (934) = 
3.47, p < .01, d = .23, and fibromyalgia-related difficulties, t (934) = 6.27, p = .04, d = .41. 
There was no difference between participants who were taking medication and those who were 
not for the remaining study variables (all p’s > .05).  
TABLE 1 ABOUT HERE 
Factor Structure 
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 The five competing factor structure models were estimated. Fit statistics for each 
model are reported in Table 2. The three factor model (Model 4) demonstrated a better fit 
than either the one or two factor models (Models 1 to 3), but the fit of this model still fell 
below our criteria for good fit. The revised three factor model (Model 5) in contrast met our 
criteria for adequate fit. Parameter estimates for this final model are reported in Table 3. All 
standardized factor loadings were above .40, meeting guidelines for minimum factor loadings 
within factor analysis.38 Item 12, “There are things I try not to think about” introduced a 
degree of ambiguity around whether it was better placed with the Non-suppression/reactivity 
factor or Non-judging/control factor. We did test an alternative 3-factor model where item 12 
loaded onto the former rather than latter factor, but found this was an even poorer fit to the 
data, Χ2 (62) = 852.90, CFI = .90, TFI = .87, RMSEA = .12. 
Modification indices for Model 5 suggested this model could be further improved by 
allowing item two (“I try to distract myself when I feel unpleasant emotions”) to cross-load 
on to the awareness factor as well as the non-suppression/reactivity factor. Cross-loading 
items can create difficulties in using self-report measures, since the same items contribute to 
different subscales, which can limit the use of different subscales together within the same 
statistical model (e.g., predictors in a regression). For these practical reasons we did not allow 
this cross-loading. Additionally, where we allowed this cross-loading, the standardized 
loading of this item onto the awareness factor was small (< .3). We calculated generalised 
Cook’s distances for this final model using the FAOUTLIER 40 package for R, which 
accounts for the ordinal nature of the data. The largest Cook’s distance (.0002) fell below the 
recommended cut-off of 4/N = 0.00441 and thus was not treated as an overly influential case. 
 In the final model both Non-judging/control and Non-suppression/reactivity factors 
were highly correlated. However, they demonstrated distinct correlations with the third 
Awareness factor, whereby the Non-judging/control factor had no relationship with this 
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factor but Non-suppression/reactivity was moderately negatively correlated with Awareness. 
Thus awareness was unrelated to the tendency to judge internal states, but was related to a 
greater tendency to try and suppress or avoid negative internal states.  
TABLE 2 ABOUT HERE 
TABLE 3 ABOUT HERE 
Factor Invariance 
 First dimensional and configural invariance was assessed by estimating the final 
model (revised three factor model) across the two meditation sub-samples (meditators N = 
315; non-meditators N = 621). Meditators were defined here on the basis of some experience 
of mediation irrespective of duration. The model fit adequately in both cases but better for 
meditators, scaled Χ2 (62) = 248.48, CFI = .97, TFI = .96, RMSEA = .07, than non-
meditators, scaled Χ2 (62) = 215.99, CFI = .94, TFI = .92, RMSEA = .09. In both models all 
standardized factor loadings were good (> .4). Dimensional and configural invariance was 
therefore supported. Metric invariance was not, however, supported, as a model where factor 
loadings were constrained to be equal across groups was a significantly worse fit than one 
where these were free, scaled ΔΧ2 (10) = 15.02, P  = .02. The factor loading for item 16 
varied more noticeably between groups (standardized loadings; meditators: .75, non-
meditators:  .87) and the wording (“If there is something I don’t want to think about, I’ll try 
many things to get it out of my mind”) was more ambiguous than others with regards to the 
specific strategies one might try to put thoughts out of their mind. We therefore tested a 
partial metric invariance, whereby all factor loadings were constrained to be equal except that 
associated with item 16. Notably, partial metric invariance was supported, ΔΧ2 (9) = 9.61, P 
= .10. We then tested partial scalar invariance, comparing the metric invariance model to one 
where item thresholds were also constrained to be equal across groups (again with the 
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exception of item 16), ΔΧ2 (36) = 9.28, P = .73. In summary partial scalar invariance was 
supported across the two groups.  
Reliability & Validity 
 Total scores for the three subscales derived from the three factor model were 
calculated by summing the relevant items. Internal reliability for each subscale is reported in 
Table 4. Internal reliability exceeded α = .70 for all subscales except for Awareness, likely 
due to the fewer items in this subscale (k = 3). Nonetheless reliability for this subscale was 
still adequate (α = .62). Correlations with decentring and affect are also reported in Table 4. 
Multiple regressions were undertaken to explore the relationship between the three subscales 
and decentring, positive affect and negative affect. The results of these analyses are in Table 
5. Residuals were homoscedastic and normally distributed within all regression analyses with 
the exception of the regression of negative affect onto the PMS subscales, where mild 
heteroscedasticity was present. Testing for significance using bootstrapped confidence 
intervals 42 with 5000 resamples led to equivalent results. Multicolinearity was not identified 
(Tolerance > .2).43 There were no influential outliers identified in any of the regression 
analyses. All models were significant. Both Awareness and Non-judging/control predicted 
greater decentring, positive affect and less negative affect. In contrast, Non-
suppression/reactivity predicted less decentring (e.g., those who make less use of avoidance 
and suppression also report less decentring) and less positive affect decentring (e.g., those 
who make less use of avoidance and suppression also report less positive affect) but was 
unrelated to negative affect. 
TABLE 4 ABOUT HERE 
TABLE 5 ABOUT HERE 
Discussion 
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 Considering the high levels of distress often associated with fibromyalgia, and the 
potential for mindfulness as a therapeutic tools, valid measure of DM in this population are 
needed, yet no DM measures exist that we are aware of that have been fully validated in a 
fibromyalgia population. Here we aimed to validate the PMS within a sample of individuals 
with fibromyalgia, using CFA to compare five alternative factor models to determine the best 
fitting structure. The results supported a revised 3-factor structure for the PMS when used in 
this population. This revised structure extends on the originally hypothesised structure of the 
PMS 13 in two important ways. First, the idea of separate Non-judging/control and Non-
suppression/reactivity factors was supported over a single acceptance factor. This distinction 
captures the idea that the actual use of avoidance and suppression as a means of managing 
negative internal states may be separate to an individual’s judgment of such states as 
problematic and the desire to control such states. The latter Non-judging/control factor could 
be understood as a set of meta-beliefs concerning internal states,21 whilst the former Non-
suppression/reactivity factor concerns a specific coping strategy. The Non-judging/control 
factor may also be similar to the idea of an intolerance of certain emotional or cognitive 
states.44 The Non-judging/control and Non-suppression/reactivity factors were correlated as 
would be expected, since a wish to control certain internal states is naturally liable to lead to 
specific attempts to suppress or avoid these. The Non-judging/control factor is probably 
closer than the Non-suppression/reactivity factor to the underlying idea of acceptance within 
the DM literature. Second, the revised PMS excludes those items of the Awareness subscale 
that could potentially overlap with a hypervigilance of internal states. A hypervigilance to 
internal states has been reported in chronic pain conditions including fibromyalgia, and may 
contribute to the emergence of the disorder.22,23 With this in mind, an Awareness factor which 
focuses on the awareness of sensory and external experiences is one way of assessing the 
awareness component of DM whilst avoiding this overlap.  
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 The factor inter-correlations further support the distinction between Non-
judging/control and Non-suppression/reactivity, since these showed different relationships 
with Awareness. In particular, greater reported Awareness was associated with a greater 
tendency to attempt to suppress or avoid internal states. This is not unexpected, since the 
ability to suppress or avoid and internal state necessitates a certain level of awareness of these 
experiences. Moreover, as this is a sample who are struggling with a chronic pain condition, 
for whom avoidant coping may be a common way of managing distress, such a relationship is 
understandable. It will be important to test if similar factor structures and relationships 
emerge within other samples, including mixed chronic pain samples. 
 The results support the partial scalar invariance of the PMS across meditators and 
non-mediators. Scalar invariance is necessary for group comparisons on factor means to be 
meaningful 25 and as such these findings support the use of this measure in chronic pain 
populations to compare those with and without experience of meditation. However, as this 
invariance was only partial an uncertainty around the use of item 16 of the PMS remains. 
This is problematic only for the Non-suppression/reactivity factor, where this item loads and 
so it may be that clinicians and researchers using the PMS within this population consider 
dropping this item from this subscale or make comparisons on this subscale cautiously. 
Notably, the reactivity embodied in the Non-suppression/reactivity factor may be better 
conceptualised as an outcome of DM 14 rather than a core facet of DM, and so it may also be 
that this subscale is dropped leaving just the Awareness and Non-judging/control subscales. 
This conceptualisation is also in-line with Bishop and colleagues 14 definition. 
 The relationships the revised PMS factors had with decentring, negative affect and 
positive affect partially supported hypotheses. As predicted decentring, which involves an 
awareness and recognition of thoughts and feelings, was highly correlated with the 
Awareness factor. Decentring was also correlated with the Non-judging/control factor, which 
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would be expected since decentring is to a certain extent incompatible with a desire to control 
thoughts and feelings.27 Reporting more mindful awareness of one’s environment and a lesser 
tendency to judge or wish to control negative internal states was linked to greater positive 
affect, which is consistent with the wider mindfulness literature.26 Notably, the Non-
judging/control factor was also strongly related to negative affect. This relationship is 
consistent with meta-cognitive models of distress which suggest it is the negative meta-
beliefs concerning internal states and processes that underlie the emergence of distress.21, 45 
The Non-suppression/reactivity factor, once overlapping variance with other PMS subscales 
was accounted for, was negatively related to positive affect (contrary to hypotheses), so that 
those who reported more of a tendency to use avoidance and suppression also tended to 
report more positive affect, although this effect was small. This finding suggests a more 
nuanced understanding of avoidance and suppression techniques, which suggests these 
coping strategies may have benefits for those with chronic pain conditions, leading to more 
positive emotions. Thus the current study suggests it is an individual’s beliefs about aversive 
internal states and their wish to control these that may be more problematic than the actual 
tendency to adopt avoidance and suppression as a coping strategy. Further confirmation of 
these findings is needed, however. 
 A few key methodological issues deserve comment. It should be noted that the study 
did not look at measurement invariance between the FM group and other samples. The 
current findings do suggest an alternative factor structure to the original development study 
(which took place in students) and so a test of measurement invariance between a student and 
FM population would be of interest. This was not however the goal of the current study. The 
study used a cross-sectional design. Therefore, it is possible, that severity of pain and/or 
mood states at the time of completing the measures may have influenced reports. Future 
research would benefit from testing on more than one occasion to assess test-retest reliability 
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of the measures within this population. While we tested the revised 3-factor model across two 
meditation sub-samples (meditators vs. non-meditators), it should be acknowledged that the 
meditator group varied considerably on the duration of meditative practice, nor where 
specific types of meditative practices reported. 
 It could be argued that the revised Awareness factor by not capturing mindful 
awareness of emotions and thoughts may not capture the full content of the construct of 
mindful awareness. However, we would argue this issue of the breadth of the factor needs to 
be weighed up against the dangers of confounding mindful awareness with hypervigilance in 
those with fibromyalgia. Notably, the results do not rule of the possibility of alternative, 
carefully worded items being introduced in the PMS that better capture this aspect of 
mindfulness. Further work in this area would be valuable. The small number of items 
remaining (k = 3) when the potentially confounding items are removed from this subscale 
means that it should be used with caution, and it may be that additional items more suited to a 
chronic pain population could be added. The presence of fibromyalgia was based on self-
reported diagnosis, and not confirmed by a clinician or diagnostic tests. This may have led to 
the current sample including individuals who would not meet formal diagnostic criteria for 
fibromyalgia taking part, although levels of reported symptomology were similar to clinical 
groups. Moreover, checks of diagnosis would have added extra burden and limited the 
attainable sample size, which would have been problematic for large-sample size techniques 
like CFA. 
The online methodology facilitated the recruitment of a large sample of participants, 
which may have been more challenging if face-to-face assessments had been used. This 
approach may have other advantages, such as supporting more honest and open responding 
due to the anonymous nature of online surveys. However, this online design meant that more 
in depth interview-based assessments, which could have been used to confirm the presence of 
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fibromyalgia, were not possible. A cross-sectional design was adopted as it places fewer 
demands on participants’ time and the resources of the research team but this meant some 
psychometric properties requiring a prospective design (e.g., test re-test reliability). The 
sample were recruited via adverts placed in Fibromyalgia charities. It is unclear how 
representative such individuals are of the wider population of those with fibromyalgia but 
severity of fibromyalgia was similar to previous samples. 
Despite these limitations, our study identified a more optimal revised 3-factor PMS 
structure in a fibromyalgia population. As such, it represents an important development on 
the originally hypothesized PMS structure (Cardaciotto et al., 2008), extends theoretical 
understanding of these psychological constructs and provides a validated clinical assessment 
tool for use within the fibromyalgia population. The PMS may therefore provide one tool for 
pain clinics and individual clinicians working with those with fibromyalgia to determine 
baseline levels of DM, which in turn is useful information for guiding interventions. Those 
particularly low in DM may, for example, benefit more from MBIs. The results also support 
the suggestion that practitioners should be wary of those items of the PMS that focus on 
awareness of internal states. Lastly, the current study supports the suggestion that low scores 
on the Non-judging /Control may be particularly informative in terms of understanding he 
distress patients experience, an observation consistent with psychological models of chronic 
pain.
21 
 
 
Acknowledgements 
We would like to Acknowledge Dr Jen Unwin for her help in undertaking this project.  
22 
 
 
Declaration of Interest 
None
23 
 
 
References 
1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al: 
The American-college-of-rheumatology 1990 criteria for the classification of 
fibromyalgia - report of the multicenter criteria committee. Arthritis Rheum 3:160-172, 
1990. 
2. Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM: Psychiatric comorbidities 
in a community sample of women with fibromyalgia. Pain 124: 117-125, 2006. 
3. Gormsen L, Rosenberg R, Bach F W, Jensen TS. Depression, anxiety, health-related 
quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. 
European Journal of Pain 127: 127e1-127e8, 2010. 
4. Abeles M, Solitar BM, Pillinger MH, Abeles AM: Update on fibromyalgia therapy. Am J 
Med 121: 555-561, 2008. 
5. Turk DC: Clinical effectiveness and cost-effectiveness of treatments for patients with 
chronic pain. Clin J Pain: 18: 355-365, 2002. 
6. Vlaeyen JWS, Morley S: Cognitive-behavioral treatments for chronic pain - what works 
for whom? Clin J Pain 21:1-8, 2005. 
7. Grossman P, Tiefenthaler-Gilmer U, Raysz A, Kesper U: Mindfulness training as an 
intervention for fibromyalgia: Evidence of post intervention and 3-year follow-up 
benefits in well-being. Psychotherapy and Psychosomatics 76: 226-233, 2007. 
8. Wicksell RK., Kemani M, Jensen K., Kosek E, Kadetoff D, Sorjonen K., et al: 
Acceptance and commitment therapy for fibromyalgia: A randomized controlled trial. 
European Journal of Pain 17: 599-611, 2013. 
9. Zautra AJ, Davis MC, Reich JW, Tennen H, Irwin MR, Nicassio P, et al: Comparison of 
cognitive behavioral and mindfulness meditation interventions on adaptation to 
24 
 
 
rheumatoid arthritis for patients with and without history of recurrent depression. J 
Consult Clin Psychol 76: 408-421, 2008. 
10. Brown KW, Ryan RM: The benefits of being present: Mindfulness and its role in 
psychological well-being. J Pers Soc Psychol 84: 822-848, 2003. 
11. Kabat-Zinn J. Mindfulness-based interventions in context: Past, present and future. 
Clinical Psychology: Science and Practice 10: 144-156, 2003. 
12. Baer RA, Hopkins J, Krietemeyer J, Smith GT, Toney L: Using self-report assessment 
methods to explore facets of mindfulness. Assessment 13: 27-45, 2006. 
13. Cardaciotto L. Herbert JD, Forman EM, Moitra E, Farrow V: The assessment of present-
moment awareness and acceptance - the Philadelphia mindfulness scale. Assessment 15: 
204-22, 2008. 
14. Bishop SR, Lau M, Shapiro S, Carlson L, Anderson ND, Carmody J, et al: Mindfulness: 
A proposed operational definition. Clinical Psychology: Science and Practice 1: 230-241, 
2004. 
15. McCraken LM, Carson JW, Eccleston C, Keefe FJ. Acceptance and change in the 
context of chronic pain 109: 1-2, 2004. 
16. Eccleston C: Role of psychology in pain management. British Journal of Anaesthesia 87: 
144-155, 2001. 
17. Cebolla A, García-Palacios A, Soler J, Guillen V, Baños R, Botella C: Psychometric 
properties of the Spanish validation of the Five Facets of Mindfulness Questionnaire 
(FFMQ). European Journal of Psychiatry 26: 118–126, 2012. 
18. Cebolla A, Luciano JV, DeMarzo MP, Navarro-Gil M, Garcia-Campayo J: Psychometric 
properties of the Spanish version of the Mindful Attention Awareness Scale (MAAS) in 
patients with fibromyalgia. Health and Quality of Life Outcomes 11, 2003. 
25 
 
 
19. Tran US, Glück TM, Nader IW: Investigating the Five Facet Mindfulness Questionnaire 
(FFMQ): Construction of a short form and evidence of a two-factor higher order 
structure of mindfulness. J Clin Psychol 69: 951-965, 2013. 
20. Veehof MM, Klooster P, Taal E, Westerhof GJ, Bohlmeijer ET: The psychometric 
properties of the Five Facet Mindfulness Questionnaire in patients with fibromyalgia. 
Clin Rheumatol 30: 1045–1054, 2011. 
21. Papageorgiou C, Wells A: Nature, functions, and beliefs about depressive rumination.  
Depressive rumination: Nature, theory and treatment. Edited by Papageorgiou C, Wells 
A, John Wiley & Sons, Chichester, 2004. 
22. Crombez G, Eccleston C, Van den Broeck A, Goubert L, Van Houdenhove B: 
Hypervigilance to pain in fibromyalgia: The mediating role of pain intensity and 
catastrophic thinking about pain. The Clinical Journal of Pain 20: 98-102, 2004. 
23. Duschek S, Werner NA, Limbert N, Winkelmann A, Montoya P: Attentional bias 
towards negative information in patients with fibromyalgia syndrome.  Pain Medicine 
15: 603-612, 2014. 
24. Van Dam NT, Earleywine M, Danoff-Burg S: Differential item function across 
mediators and non-mediators on the five facet mindfulness questionnaire. Personality 
and Individual Differences 47: 516-521, 2009. 
25. Gregorich SE: Do self-report instruments allow meaningful comparisons across diverse 
population groups? Testing measurement invariance using the confirmatory factor 
analysis framework. Med Care 44: S78–S94, 2006. 
26. Giluk TL: Mindfulness, big five personality, and affect: A meta-analysis. Personality and 
Individual Difference 47: 805-811, 2009. 
26 
 
 
27. Fresco DM, Moore MT, van Dulmen MHM, Segal ZV, Ma SH, Teasdale JD, Williams 
JMG: Initial psychometric properties of the Experiences Questionnaire: Validation of a 
self-report measure of decentering. Behavior Therapy 38: 234-246, 2007. 
28. Segal ZV, Teasdale JD, Williams M: Mindfulness-based cognitive therapy for 
depression, Guilford Press, New York, 2002. 
29. Shapiro SL, Carlson LE, Astin JA, Freedman B:  Mechanisms of mindfulness. J Clin 
Psychol 62: 373-386, 2006. 
30. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL: The Revised 
Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties. 
Arthritis Research & Therapy 11:  R120, 2009. 
31. Watson D, Clark LA, Tellegen A: Development and validation of brief measures of 
positive and negative affect - the Panas Scales. J Pers SocPsychol 54: 1063-1070, 1988. 
32. Crawford JR, Henry JD: The positive and negative affect schedule (PANAS): Construct 
validity, measurement properties and normative data in a large non-clinical sample. 
British Journal of Clinical Psychology 43: 245-265. 
33. Kline RB: Principles and practice of structural equation modeling (3rd Edition ed.), 
Guilford Press, New York, 2010.  
34. Muthén LK., Muthén BO. Mplus user’s guide. Seventh edition. Muthén & Muthén, Los 
Angeles, 1998-2012. 
35. Bentler PM: Comparative fit indices in structural models. Psychol bull 107: 238-246, 
1900. 
36. Hu L, Bentler PM: Cutoff criteria for fit indexes in covariance structure analysis: 
Conventional criteria versus new alternatives. Structural Equation Modeling: A 
Multidisciplinary Journal 6: 1-55, 1999. 
27 
 
 
37. Jöreskog KG, Sörbom D: Structural equation modeling with the SIMPLIS command 
language,  Scientific Software Inc, Chicago, 1993. 
38. Costello, AB, Osborne JW: Best practices in exploratory factor analysis: Four 
recommendations for getting the most from your analysis. Practical Assessment, 
Research & Evaluation 10: 1-9, 2005. 
39. Satorra A: Scaled and adjusted restricted tests in multi-sample analysis of moment 
structures. Innovations in multivariate statistical analysis: A Festschrift for Heinz 
Neudecker. Edited by Heijmans RDH, Pollock DSG, Satorra A, Kluwer Academic 
Publishers, London, 2010. 
40. Chalmers P: Faoutlier: Influential case detection methods for factor analysis and SEM. R 
package version 0.4, 2013. 
41. Bollen KA, Jackman RW: Regression diagnostics: An expository treatment of outliers 
and influential cases. Modern methods of data analysis. Edited by Fox J, Long JS, Sage, 
Newbury Park, 1990. 
42. Mooney CZ, Duval RD: Bootstrapping: A non-statistical approach to statistical 
inference, Sage Publications, London, 1993. 
43. Menard S: Applied logistic regression analysis: Sage university series on quantitative 
applications in the social sicences. Sage, Thousand Oaks, 1995. 
44. Koerner N. Dugas MJ: A cognitive model of generalized anxiety disorder: The role of 
intolerance of uncertainty. Worry and its psychological disorders: Theory, assessment 
and treatment. Edited by Davey GCL, Wells A, Wiley, Chichester, 2006. 
45. Wells A: The metacognitive model of GAD: Assessment of meta-worry and relationship 
with DSM-IV Generalized Anxiety Disorder. Cognitive Therapy & Research 29: 107-
121, 2005.
28 
 
 
Table 1 
Descriptive Statistics 
Variable Mean Standard Deviation Range 
PA 23.35  8.45 10 – 48 
NA 26.31 9.35 10 – 50 
M’ful aware 36.48 5.94 13 – 50 
M’ful accept 25.31 6.60 10 – 50 
Decentering 33.02 6.96 14 – 55 
FM 68.54 18.52 5 – 100 
Note. PA = positive affect; NA = negative affect, M’ful aware = mindful awareness; M’ful 
accept = mindful acceptance; FM = fibromyalgia-related difficulties.  
  
29 
 
 
 
Table 2 
Fit Statistics for the Completing CFA Models 
 
 
   Model fit 
 Model Scaled 
Χ2 
df CFI TLI RMSEA (90% 
CI) 
Model 1: 1 factor 4927.51 170 .55 .50 .17 (.17, .18) 
Model 2: 2 factor 2283.02 169 .80 .78 .12 (.11, .12) 
Model 3: 2 factor, correlated errors 2108.41 164 .82 .79 .11 (.11, .12) 
Model 4: 3 factor 1831.03 167 .84 .82 .10 (.10, .11) 
Model 5: revised 3 factor 406.72 62 .96 .94 .08 (.07, .08) 
30 
 
 
Table 3 
Parameter Estimates for the Final Model 
 
 
 
 
 
 
 
 
 
 
 
 
 
*All loadings and correlations significant (p  < .001) with the exception of this one 
 
 
Parameter Unstandardized estimate Standardized estimate 
Factor loadings   
Awareness (Aw)   
Item 3 1.00 .52 
Item 5 1.28 .67 
Item 9 1.41 .74 
Non-suppression/reactivity (NR)   
Item 2 1.00 .47 
Item 6 1.37 .65 
Item 16 1.74 .83 
Item 18 1.44 .68 
Item 20 1.49 .71 
Non-judging/control (NC)   
Item 4 1.00 .75 
Item 8 0.81 .61 
Item 10 1.05 .79 
Item 12 1.15 .86 
Item 14 0.87 .65 
Factor covariances & correlations   
Aw – NR -0.06 -.24 
Aw – NC* 0.02 .04 
NR - NC 0.25 .70 
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Table 4 
Descriptive statistics, Reliability, Correlations and Regression Results for PMS Subscales 
a Spearman’s correlations; * p < .05; Aw = Awareness; NR = Non-suppression/reactivity; NC 
= Non-judging/control
 Descriptives Zero-order 
Correlationsa 
  
Variable Alpha Mean SD Decentring Positive 
Affect 
Negative 
affect 
Aw .62 11.05 2.51 .43* .26* -.13* 
NR .77 12.76 3.48 -.01 .03 -.28* 
NC .82 12.54 4.04 .41* .37* -.62* 
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Table 5 
Results of Regression of Outcome Variables onto PMS Subscales 
 
 
 
 
 
* p < .001; a P = .19; Aw = Awareness; NR = Non-suppression/reactivity; NC = Non-
judging/control 
 Decentring PA  NA 
Predictor R2 B rsp
 
 
R2 B rsp
  R2 B rsp
 
Aw .41* 1.06* .37  .22* 0.76* .22  40* -0.42* -.11 
NR  -0.47* -.19   -0.39* -.13   0.11a .03 
NC  0.94* .45   0.95* .38   -1.48* -.53 
